Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028

According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/

Retail Pharmacy to Dominate the Ankylosing Spondylitis Market:
Based on the distribution channel type, retail pharmacy holds the highest market share. The major factor for the rise of this segment is the increasing number of retail pharmacies. Moreover, retail pharmacy is now available in every nook and corner of the country which makes them easily available for the patients to reach there which can drive the growth of the global ankylosing spondylitis market. Apart from this, an increasing number of patients can also drive the growth of the market.

North America Ankylosing Spondylitis Market:
North America, followed by Europe, leads the global ankylosing spondylitis market due to the increasing prevalence of ankylosing spondylitis in these regions. North America leads the global market due to entrenched research infrastructure, increasing funding from public and private sectors, and rising collaborations among global key players have contributed to increasing the sales of ankylosing spondylitis in this region. According to the Musculo health report, in 2018, 200,000 cases were registered in the UK for people suffering from ankylosing spondylitis. Apart from this, the major factor that drives the market in this region is the increasing acceptance of ankylosing spondylitis treatment among people.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Ankylosing Spondylitis market further reveals that the key players are implementing strategies such as the extension of product collection through research and development activities, product launches, acquisitions, mergers, and strategic alliances to improve their market position and strengthen the market revenue share.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=60547

The ankylosing spondylitis market is segmented based on drug class type, distribution channel, and region.
Based on the drug class type, the market is segmented into the following:
• NSAIDs
• TNF inhibitors
• Others

Based on the distribution channel type, the market is segmented into the following:
• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

Based on the region, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=60547

Key players' profiles in the ankylosing spondylitis market report are AbbVie, Inc, Amgen, Inc, Eli Lilly and Company, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co. Inc, Novartis AG, Pfizer, Inc., Reliance Life Sciences Pvt. Ltd, UCB, Inc.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.